Redox-responsive polyanhydride micelles for cancer therapy

Biomaterials

Volumn 35, Issue 9, 2014, Pages 3080-3090

  Wang, Jie ^a   Yang, Guang ^a   Guo, Xing ^a   Tang, Zhaomin ^a   Zhong, Zhendong ^b   Zhou, Shaobing ^a  

^a SOUTHWEST JIAOTONG UNIVERSITY   (China)

^b SICHUAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Cancer therapy; Drug delivery; Micelle; Nanocarrier; Redox responsive

Indexed keywords

CANCER THERAPY; DRUG DELIVERY; MICELLE; NANOCARRIER; REDOX-RESPONSIVE;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BIOCOMPATIBLE MATERIALS; CELL CYCLE; CURCUMIN; DECANOIC ACIDS; DICARBOXYLIC ACIDS; FLOW CYTOMETRY; GLUTATHIONE; HELA CELLS; HUMANS; HYDROXYBENZOATE ETHERS; IN SITU NICK-END LABELING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICE; MICE, INBRED BALB C; MICELLES; NEOPLASMS; OXIDATION-REDUCTION; POLYANHYDRIDES; POLYETHYLENE GLYCOLS; TISSUE DISTRIBUTION;

EID: 84895041194     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.12.025     Document Type: Article

References (52)

1. Peer D., Karp J.M., Hong S., Farokhzad O.C., Margalit R., Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2007, 2:751-760.
2. Newland B., Zheng Y., Jin Y., Abu-Rub M., Cao H., Wang W., et al. Single cyclized molecule versus single branched molecule: a simple and efficient 3D "knot" polymer structure for nonviral gene delivery. J Am Chem Soc 2012, 134:4782-4789.
3. Farokhzad O.C., Langer R. Impact of nanotechnology on drug delivery. ACS Nano 2009, 3:16-20.
4. Duncan R. The dawning era of polymer therapeutics. Nat Rev Drug Discov 2003, 2:347-360.
5. Fox M.E., Szoka F.C., Frechet J.M. Soluble polymer carriers for the treatment of cancer: the importance of molecular architecture. Acc Chem Res 2009, 42:1141-1151.
6. Deng C., Jiang Y., Cheng R., Meng F., Zhong Z. Biodegradable polymeric micelles for targeted and controlled anticancer drug delivery: promises, progress and prospects. Nano Today 2012, 7:467-480.
7. Wang C., Wang Z., Zhang X. Amphiphilic building blocks for self-assembly: from amphiphiles to supra-amphiphiles. Acc Chem Res 2012, 45:608-618.
8. Nicolas J., Mura S., Brambilla D., Mackiewicz N., Couvreur P. Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery. Chem Soc Rev 2013, 42:1147-1235.
9. Kazunori K., Glenn S.K., Masayuki Y., Teruo O., Yasuhisa S. Block copolymer micelles as vehicles for drug delivery. J Control Release 1993, 24:119-132.
10. Allen T.M., Cullis P.R. Drug delivery systems: entering the mainstream. Science 2004, 303:1818-1822.
11. Hu X., Liu S., Chen X., Mo G., Xie Z., Jing X. Biodegradable amphiphilic block copolymers bearing protected hydroxyl groups: synthesis and characterization. Biomacromolecules 2008, 9:553-560.
12. Basarkar A., Singh J. Poly (lactide-co-glycolide)-polymethacrylate nanoparticles for intramuscular delivery of plasmid encoding interleukin-10 to prevent autoimmune diabetes in mice. Pharm Res 2009, 26:72-81.
13. Sun Y., Yan X., Yuan T., Liang J., Fan Y., Gu Z., et al. Disassemblable micelles based on reduction-degradable amphiphilic graft copolymers for intracellular delivery of doxorubicin. Biomaterials 2010, 31:7124-7131.
14. Guo X., Shi C., Wang J., Di S., Zhou S. pH-triggered intracellular release from actively targeting polymer micelles. Biomaterials 2013, 34:4544-4554.
15. Rosen H.B., Chang J., Wnek G.E., Linhardt R.J., Langer R. Bioerodible polyanhydrides for controlled drug delivery. Biomaterials 1983, 4:131-133.
16. Kumar N., Langer R.S., Domb A.J. Polyanhydrides: an overview. Adv Drug Deliv Rev 2002, 54:889-910.
17. Zhao A., Zhou S., Zhou Q., Chen T. Thermosensitive micelles from PEG-based ether-anhydride triblock copolymers. Pharm Res 2010, 27:1627-1643.
18. Chen T., Guo X., Liu X., Shi S., Wang J., Shi C., et al. A strategy in the design of micellar shape for cancer therapy. Adv Healthcare Mater 2012, 1:214-224.
19. Griset A.P., Walpole J., Liu R., Gaffey A., Colson Y.L., Grinstaff M.W. Expansile nanoparticles: synthesis, characterization, and in vivo efficacy of an acid-responsive polymeric drug delivery system. J Am Chem Soc 2009, 131:2469-2471.
20. Wang J., Sun X., Mao W., Sun W., Tang J., Sui M., et al. Tumor redox heterogeneity-responsive prodrug nanocapsules for cancer chemotherapy. Adv Mater 2013, 25:3670-3676.
21. Yang Y., Wang J., Zhang X., Lu W., Zhang Q. A novel mixed micelle gel with thermo-sensitive property for the local delivery of docetaxel. J Control Release 2009, 135:175-182.
22. Dai J., Lin S., Cheng D., Zou S., Shuai X. Interlayer-crosslinked micelle with partially hydrated core showing reduction and pH dual sensitivity for pinpointed intracellular drug release. Angew Chem Int Ed Engl 2011, 50:9404-9408.
23. Yoon S., Kim W.J., Yoo H.S. Dual-responsive breakdown of nanostructures with high doxorubicin payload for apoptotic anticancer therapy. Small 2013, 9:284-293.
24. Liu J., Pang Y., Zhu Z., Wang D., Li C., Huang W., et al. Therapeutic nanocarriers with hydrogen peroxide-triggered drug release for cancer treatment. Biomacromolecules 2013, 14:1627-1636.
25. Cheng R., Feng F., Meng F., Deng C., Feijen J., Zhong Z. Glutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene delivery. J Control Release 2011, 152:2-12.
26. Wei H., Zhuo R.-X., Zhang X.-Z. Design and development of polymeric micelles with cleavable links for intracellular drug delivery. Prog Polym Sci 2013, 38:503-535.
27. Gilbert H.F. Thiol/disulfide exchange equilibria and disulfidebond stability 1995, 8-28. Methods Enzymol Academic Press. P. Lester (Ed.).
28. Shim M.S., Kwon Y.J. Stimuli-responsive polymers and nanomaterials for gene delivery and imaging applications. Adv Drug Deliv Rev 2012, 64:1046-1059.
29. Liu J., Pang Y., Chen J., Huang P., Huang W., Zhu X., et al. Hyperbranched polydiselenide as a self assembling broad spectrum anticancer agent. Biomaterials 2012, 33:7765-7774.
30. Liu J., Huang W., Pang Y., Huang P., Zhu X., Zhou Y., et al. Molecular self-assembly of a homopolymer: an alternative to fabricate drug-delivery platforms for cancer therapy. Angew Chem Int Ed Engl 2011, 50:9162-9166.
31. Cheng Z., Al Zaki A., Hui J.Z., Muzykantov V.R., Tsourkas A. Multifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilities. Science 2012, 338:903-910.
32. Meng F., Hennink W.E., Zhong Z. Reduction-sensitive polymers and bioconjugates for biomedical applications. Biomaterials 2009, 30:2180-2198.
33. Tang H., Murphy C.J., Zhang B., Shen Y., Van Kirk E.A., Murdoch W.J., et al. Curcumin polymers as anticancer conjugates. Biomaterials 2010, 31:7139-7149.
34. Murphy C.J., Tang H., Van Kirk E.A., Shen Y., Murdoch W.J. Reproductive effects of a pegylated curcumin. Reprod Toxicol 2012, 34:120-124.
35. Yu H., Huang Q. Improving the oral bioavailability of curcumin using novel organogel-based nanoemulsions. J Agric Food Chem 2012, 60:5373-5379.
36. Akbari H., D'Emanuele A., Attwood D. Effect of geometry on the erosion characteristics of polyanhydride matrices. Int J Pharm 1998, 160:83-89.
37. Hanes J., Chiba M., Langer R. Degradation of porous poly(anhydride-co-imide) microspheres and implications for controlled macromolecule delivery. Biomaterials 1998, 19:163-172.
38. Wang Y.J., Pan M.H., Cheng A.L., Lin L.I., Ho Y.S., Hsieh C.Y., et al. Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharm Biomed Anal 1997, 15:1867-1876.
39. Fleige E., Quadir M.A., Haag R. Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: concepts and applications. Adv Drug Deliv Rev 2012, 64:866-884.
40. Hubbell J.A. Enhancing drug function. Science 2003, 300:595-596.
41. Sahoo S.K., Ma W., Labhasetwar V. Efficacy of transferrin-conjugated paclitaxel-loaded nanoparticles in a murine model of prostate cancer. Int J Cancer 2004, 112:335-340.
42. Yan Y., Johnston A.P., Dodds S.J., Kamphuis M.M., Ferguson C., Parton R.G., et al. Uptake and intracellular fate of disulfide-bonded polymer hydrogel capsules for Doxorubicin delivery to colorectal cancer cells. ACS Nano 2010, 4:2928-2936.
43. Ravindran J., Prasad S., Aggarwal B.B. Curcumin and cancer cells: how many ways can curry kill tumor cells selectivelyα. AAPS J 2009, 11:495-510.
44. Beevers C.S., Li F., Liu L., Huang S. Curcumin inhibits the mammalian target of rapamycin-mediated signaling pathways in cancer cells. Int J Cancer 2006, 119:757-764.
45. Song Z., Feng R., Sun M., Guo C., Gao Y., Li L., et al. Curcumin-loaded PLGA-PEG-PLGA triblock copolymeric micelles: preparation, pharmacokinetics and distribution in vivo. J Colloid Interface Sci 2011, 354:116-123.
46. Smola M., Vandamme T., Sokolowski A. Nanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseases. Int J Nanomed 2008, 3:1.
47. Maeda H., Wu J., Sawa T., Matsumura Y., Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release 2000, 65:271-284.
48. Lu J., Huang Y., Zhao W., Marquez R.T., Meng X., Li J., et al. PEG-derivatized embelin as a nanomicellar carrier for delivery of paclitaxel to breast and prostate cancers. Biomaterials 2013, 34:1591-1600.
49. Wang B., He X., Zhang Z., Zhao Y., Feng W. Metabolism of nanomaterialsin vivo: blood circulation and organ clearance. Acc Chem Res 2013, 46:761-769.
50. Li L., Braiteh F.S., Kurzrock R. Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis. Cancer 2005, 104:1322-1331.
51. Wang W., Cheng D., Gong F., Miao X., Shuai X. Design of multifunctional micelle for tumor-targeted intracellular drug release and fluorescent imaging. Adv Mater 2012, 24:115-120.
52. Fan H., Hu Q.D., Xu F.J., Liang W.Q., Tang G.P., Yang W.T. In vivo treatment of tumors using host-guest conjugated nanoparticles functionalized with doxorubicin and therapeutic gene pTRAIL. Biomaterials 2012, 33:1428-1436.